Form 8-K - Current report:
SEC Accession No. 0001628280-15-008578
Filing Date
2015-11-09
Accepted
2015-11-09 17:17:16
Documents
4
Period of Report
2015-11-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8k-piramalcoxpromotionagr.htm 8-K 27186
2 EXHIBIT 99.1 pressrelease-piramalcoxpro.htm EX-99.1 23889
3 cumberlandpharmaceuti_image1.jpg GRAPHIC 37721
4 piramalimage.jpg GRAPHIC 6254
  Complete submission text file 0001628280-15-008578.txt   112909
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 151216700
SIC: 2834 Pharmaceutical Preparations